Patents by Inventor Kenneth Aron

Kenneth Aron has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11614447
    Abstract: The present invention relates to analyte detection devices and methods of using such devices to detect minute quantities of a target analyte in a sample. In particular, the invention provides a method of detecting a target analyte in a sample comprising mixing the sample with a first detection conjugate and a second detection conjugate in solution, wherein the first and second detection conjugates comprise metallic nanostructures coupled to binding partners that are capable of specifically binding to the target analyte if present in the sample to form a complex between the first detection conjugate, the analyte, and the second detection conjugate, wherein a change in an optical signal upon complex formation indicates the presence of the target analyte in the sample. Methods of preparing nanostructures and nanoalloys, as well as nanostructures and nanoalloys conjugated to binding partners, are also described.
    Type: Grant
    Filed: November 29, 2021
    Date of Patent: March 28, 2023
    Assignee: Zoetis Services LLC
    Inventors: Rajesh K. Mehra, Vincent Chiang, Kenneth Aron, Jessica Frisz
  • Publication number: 20220133167
    Abstract: The present invention relates to methods of using a therapeutic system. In particular, the present invention relates to procedures and methods of using a system having hardware, software, and appliance components for assessing and entraining a non-nutritive suck (NNS) pattern in a patient. The methods include configuring the hardware and software systems to receive data from an orofacial stimulation appliance and to generate a precise therapeutic pulse profile that is actuated as a tactile stimulus. The methods also include collecting data using the orofacial stimulation appliance and delivering the tactile stimulus via the orofacial stimulation appliance to entrain an organized NNS pattern.
    Type: Application
    Filed: January 14, 2022
    Publication date: May 5, 2022
    Applicants: Innara Health, Inc., University of Kansas
    Inventors: Steven M. Barlow, David L. Stalling, Kenneth Aron
  • Publication number: 20220082562
    Abstract: The present invention relates to analyte detection devices and methods of using such devices to detect minute quantities of a target analyte in a sample. In particular, the invention provides a method of detecting a target analyte in a sample comprising mixing the sample with a first detection conjugate and a second detection conjugate in solution, wherein the first and second detection conjugates comprise metallic nanostructures coupled to binding partners that are capable of specifically binding to the target analyte if present in the sample to form a complex between the first detection conjugate, the analyte, and the second detection conjugate, wherein a change in an optical signal upon complex formation indicates the presence of the target analyte in the sample. Methods of preparing nanostructures and nanoalloys, as well as nanostructures and nanoalloys conjugated to binding partners, are also described.
    Type: Application
    Filed: November 29, 2021
    Publication date: March 17, 2022
    Inventors: Rajesh K. MEHRA, Vincent CHIANG, Kenneth ARON, Jessica FRISZ
  • Patent number: 11234607
    Abstract: The present invention relates to methods of using a therapeutic system. In particular, the present invention relates to procedures and methods of using a system having hardware, software, and appliance components for assessing and entraining a non-nutritive suck (NNS) pattern in a patient. The methods include configuring the hardware and software systems to receive data from an orofacial stimulation appliance and to generate a precise therapeutic pulse profile that is actuated as a tactile stimulus. The methods also include collecting data using the orofacial stimulation appliance and delivering the tactile stimulus via the orofacial stimulation appliance to entrain an organized NNS pattern.
    Type: Grant
    Filed: April 26, 2012
    Date of Patent: February 1, 2022
    Assignees: Innara Health, Inc., University of Kansas
    Inventors: Steven M. Barlow, David L. Stalling, Kenneth Aron
  • Patent number: 11215614
    Abstract: The present invention relates to analyte detection devices and methods of using such devices to detect minute quantities of a target analyte in a sample. In particular, the invention provides a method of detecting a target analyte in a sample comprising mixing the sample with a first detection conjugate and a second detection conjugate in solution, wherein the first and second detection conjugates comprise metallic nanostructures coupled to binding partners that are capable of specifically binding to the target analyte if present in the sample to form a complex between the first detection conjugate, the analyte, and the second detection conjugate, wherein a change in an optical signal upon complex formation indicates the presence of the target analyte in the sample. Methods of preparing nanostructures and nanoalloys, as well as nanostructures and nanoalloys conjugated to binding partners, are also described.
    Type: Grant
    Filed: August 20, 2019
    Date of Patent: January 4, 2022
    Assignee: Zoetis Services LLC
    Inventors: Rajesh K. Mehra, Vincent Chiang, Kenneth Aron, Jessica Frisz
  • Publication number: 20210378581
    Abstract: A neural analysis and treatment system includes a computing device with a memory for storing an application that is executable on a processor to receive amplitude-integrated electroencephalography (aEEG) and range-EEG (rEEG) measurements associated with a patient. The systems determine a spectral edge frequency (SEF) measurement from the received EEG measurements, and determine one or more neural characteristics of the patient according to the determined SEF, aEEG, and rEEG measurements. These neural characteristics may then be used to identify and implement an appropriate therapeutic treatment.
    Type: Application
    Filed: August 20, 2021
    Publication date: December 9, 2021
    Applicant: Innara Health, Inc.
    Inventors: Steven M. Barlow, Ph.D., David L. Stalling, Ph.D., Kenneth Aron
  • Patent number: 11096619
    Abstract: A neural analysis and treatment system includes a computing device with a memory for storing an application that is executable on a processor to receive amplitude-integrated electroencephalography (aEEG) and range-EEG (rEEG) measurements associated with a patient. The systems determine a spectral edge frequency (SEF) measurement from the received EEG measurements, and determine one or more neural characteristics of the patient according to the determined SEF, aEEG, and rEEG measurements. These neural characteristics may then be used to identify and implement an appropriate therapeutic treatment.
    Type: Grant
    Filed: July 14, 2014
    Date of Patent: August 24, 2021
    Assignee: Innara Health, Inc.
    Inventors: Steven M. Barlow, David L. Stalling, Kenneth Aron
  • Publication number: 20200110086
    Abstract: The present invention relates to analyte detection devices and methods of using such devices to detect minute quantities of a target analyte in a sample. In particular, the invention provides a method of detecting a target analyte in a sample comprising mixing the sample with a first detection conjugate and a second detection conjugate in solution, wherein the first and second detection conjugates comprise metallic nanostructures coupled to binding partners that are capable of specifically binding to the target analyte if present in the sample to form a complex between the first detection conjugate, the analyte, and the second detection conjugate, wherein a change in an optical signal upon complex formation indicates the presence of the target analyte in the sample. Methods of preparing nanostructures and nanoalloys, as well as nanostructures and nanoalloys conjugated to binding partners, are also described.
    Type: Application
    Filed: August 20, 2019
    Publication date: April 9, 2020
    Inventors: Rajesh K. MEHRA, Vincent CHIANG, Kenneth ARON, Jessica FRISZ
  • Patent number: 10429383
    Abstract: The present invention relates to analyte detection devices and methods of using such devices to detect minute quantities of a target analyte in a sample. In particular, the invention provides a method of detecting a target analyte in a sample comprising mixing the sample with a first detection conjugate and a second detection conjugate in solution, wherein the first and second detection conjugates comprise metallic nanostructures coupled to binding partners that are capable of specifically binding to the target analyte if present in the sample to form a complex between the first detection conjugate, the analyte, and the second detection conjugate, wherein a change in an optical signal upon complex formation indicates the presence of the target analyte in the sample. Methods of preparing nanostructures and nanoalloys, as well as nanostructures and nanoalloys conjugated to binding partners, are also described.
    Type: Grant
    Filed: October 31, 2017
    Date of Patent: October 1, 2019
    Assignee: Abaxis, Inc.
    Inventors: Rajesh Mehra, Vincent Chiang, Kenneth Aron, Jessica Frisz
  • Patent number: 9974476
    Abstract: A handheld device detects and measures orofacial activity, including oral cavity pressure and one or more compressions, deformations, displacements, or deflections of a pacifier engaged to the device. The compressions, deformations, displacements, or deflections of the pacifier refer to changes in the shape of the pacifier, caused by patient, relative to an initial state of the pacifier. The device translates the oral cavity pressure and compressions into an electrical signal, digitizes the electrical signal, and performs analytical processing of the digitized signal to extract physiological artifacts salient to the patient's ability to orally feed using a software application executing on a processor within the device. The device automates and simplifies the assessment of a patient's readiness to orally feed by presenting graphical and numeric scores for organization and effort of non-nutritive suck.
    Type: Grant
    Filed: January 21, 2014
    Date of Patent: May 22, 2018
    Assignee: Innara Health, Inc.
    Inventors: Kenneth Aron, David L. Stalling, John Kean, Allen Ingling
  • Publication number: 20180059104
    Abstract: The present invention relates to analyte detection devices and methods of using such devices to detect minute quantities of a target analyte in a sample. In particular, the invention provides a method of detecting a target analyte in a sample comprising mixing the sample with a first detection conjugate and a second detection conjugate in solution, wherein the first and second detection conjugates comprise metallic nanostructures coupled to binding partners that are capable of specifically binding to the target analyte if present in the sample to form a complex between the first detection conjugate, the analyte, and the second detection conjugate, wherein a change in an optical signal upon complex formation indicates the presence of the target analyte in the sample. Methods of preparing nanostructures and nanoalloys, as well as nanostructures and nanoalloys conjugated to binding partners, are also described.
    Type: Application
    Filed: October 31, 2017
    Publication date: March 1, 2018
    Inventors: Rajesh MEHRA, Vincent CHIANG, Kenneth ARON, Jessica FRISZ
  • Patent number: 9835622
    Abstract: The present invention relates to analyte detection devices and methods of using such devices to detect minute quantities of a target analyte in a sample. In particular, the invention provides a method of detecting a target analyte in a sample comprising mixing the sample with a first detection conjugate and a second detection conjugate in solution, wherein the first and second detection conjugates comprise metallic nanostructures coupled to binding partners that are capable of specifically binding to the target analyte if present in the sample to form a complex between the first detection conjugate, the analyte, and the second detection conjugate, wherein a change in an optical signal upon complex formation indicates the presence of the target analyte in the sample. Methods of preparing nanostructures and nanoalloys, as well as nanostructures and nanoalloys conjugated to binding partners, are also described.
    Type: Grant
    Filed: August 4, 2016
    Date of Patent: December 5, 2017
    Assignee: ABAXIS, INC.
    Inventors: Rajesh Mehra, Vincent Chiang, Kenneth Aron, Jessica Frisz
  • Patent number: 9662266
    Abstract: The present disclosure relates to a therapeutic system and methods of using the therapeutic system. In particular, the present disclosure relates to a system for improving an oral feeding ability of a patient including an assessment device to contact a patient and collect data related to an oral feeding ability of the patient, a computing device containing a processor to execute an assessment and therapy application, and the assessment and therapy application to receive the data related to the oral feeding ability, predict one or more areas of neurological muscle activity that need further development, and develop a neurological therapy treatment for improving the one or more areas of neurological muscle activity that need further development.
    Type: Grant
    Filed: January 21, 2014
    Date of Patent: May 30, 2017
    Assignee: Innara Health, Inc.
    Inventors: Kenneth Aron, David L. Stalling, John Kean, Allen Ingling
  • Publication number: 20170038366
    Abstract: The present invention relates to analyte detection devices and methods of using such devices to detect minute quantities of a target analyte in a sample. In particular, the invention provides a method of detecting a target analyte in a sample comprising mixing the sample with a first detection conjugate and a second detection conjugate in solution, wherein the first and second detection conjugates comprise metallic nanostructures coupled to binding partners that are capable of specifically binding to the target analyte if present in the sample to form a complex between the first detection conjugate, the analyte, and the second detection conjugate, wherein a change in an optical signal upon complex formation indicates the presence of the target analyte in the sample. Methods of preparing nanostructures and nanoalloys, as well as nanostructures and nanoalloys conjugated to binding partners, are also described.
    Type: Application
    Filed: August 4, 2016
    Publication date: February 9, 2017
    Inventors: Rajesh MEHRA, Vincent CHIANG, Kenneth ARON, Jessica FRISZ
  • Patent number: 9220654
    Abstract: The present invention relates to a therapeutic system and methods of using the therapeutic system. In particular, the present invention relates to systems having hardware, software, and appliance components for assessing and entraining a neuromuscular pattern or behavior in a patient. The methods include configuring the hardware and software systems to receive data from an orofacial stimulation appliance and to generate a precise therapeutic pulse profile that is actuated as a tactile stimulus. In one embodiment, the system and methods also include collecting data using the orofacial stimulation appliance and delivering the tactile stimulus via the orofacial stimulation appliance to entrain an organized neuromuscular pattern or behavior.
    Type: Grant
    Filed: October 31, 2014
    Date of Patent: December 29, 2015
    Assignee: Innara Health, Inc.
    Inventors: Steven M. Barlow, David L. Stalling, Kenneth Aron
  • Patent number: 9037266
    Abstract: The present invention relates to a system and method for using the system. In particular, the present invention relates to an application, executable by a processing device to assess the organization of a non-nutritive suck (NNS) pattern of a patient and to entrain an organized NNS pattern in the patient. The software system receives data from an orofacial stimulation appliance to assess the patient's natural NNS pattern and generates a precise therapeutic pulse profile that is actuated as a tactile stimulus via the orofacial stimulation appliance to entrain an organized NNS pattern.
    Type: Grant
    Filed: April 26, 2012
    Date of Patent: May 19, 2015
    Assignee: Innara Health, Inc.
    Inventors: Steven M. Barlow, David L. Stalling, Kenneth Aron
  • Publication number: 20150100003
    Abstract: The present invention relates to a therapeutic system and methods of using the therapeutic system. In particular, the present invention relates to systems having hardware, software, and appliance components for assessing and entraining a neuromuscular pattern or behavior in a patient. The methods include configuring the hardware and software systems to receive data from an orofacial stimulation appliance and to generate a precise therapeutic pulse profile that is actuated as a tactile stimulus. In one embodiment, the system and methods also include collecting data using the orofacial stimulation appliance and delivering the tactile stimulus via the orofacial stimulation appliance to entrain an organized neuromuscular pattern or behavior.
    Type: Application
    Filed: October 31, 2014
    Publication date: April 9, 2015
    Inventors: Steven M. Barlow, David L. Stalling, Kenneth Aron
  • Patent number: 8939919
    Abstract: The present invention relates to a therapeutic system and methods of using the therapeutic system. In particular, the present invention relates to systems having hardware, software, and appliance components for assessing and entraining a neuromuscular pattern or behavior in a patient. The methods include configuring the hardware and software systems to receive data from an orofacial stimulation appliance and to generate a precise therapeutic pulse profile that is actuated as a tactile stimulus. In one embodiment, the system and methods also include collecting data using the orofacial stimulation appliance and delivering the tactile stimulus via the orofacial stimulation appliance to entrain an organized neuromuscular pattern or behavior.
    Type: Grant
    Filed: April 26, 2012
    Date of Patent: January 27, 2015
    Assignees: Innara Health, Inc., University of Kansas
    Inventors: Steven M. Barlow, David L. Stalling, Kenneth Aron
  • Publication number: 20150018705
    Abstract: A neural analysis and treatment system includes a computing device with a memory for storing an application that is executable on a processor to receive amplitude-integrated electroencephalography (aEEG) and range-EEG (rEEG) measurements associated with a patient. The systems determine a spectral edge frequency (SEF) measurement from the received EEG measurements, and determine one or more neural characteristics of the patient according to the determined SEF, aEEG, and rEEG measurements. These neural characteristics may then be used to identify and implement an appropriate therapeutic treatment.
    Type: Application
    Filed: July 14, 2014
    Publication date: January 15, 2015
    Inventors: Steven M. Barlow, Ph.D., David L. Stalling, Ph.D., Kenneth Aron
  • Publication number: 20140207024
    Abstract: A cordless handheld device detects and analyzes orofacial activity based on compressions or deflections of an associated pacifier and oral cavity pressure. The device can receive and analyze data that can be used to train an infant to feed.
    Type: Application
    Filed: January 21, 2014
    Publication date: July 24, 2014
    Applicant: Innara Health, Inc.
    Inventors: Kenneth Aron, David L. Stalling, John Kean, Allen Ingling